Efficacy of Topical Herbal Anti-inflammatory Treatment (HAT1) for Treating Psoriasis: An Investigator-Initiated Open Label Study

Abstract

used for any missing data. Secondary endpoint was the percentage improvement in the Dermatology Life Quality Index (DLQI). Other parameters include percentage improvement of the Numerical Rating Scale for Itch (NRS), BSA, and PASI. One patient was excluded for the DLQI analysis due to a protocol deviation at baseline.